If you live in Australia, have been diagnosed with Non-Small Cell Lung Cancer and are aged 18 years or older, CCNSW is sharing an opportunity to participate in a research study conducted by UNSW and the UNSW Cellular Genomics Futures Institute, focusing on improving lung cancer diagnostics.
Study Overview: This study explores a new technology called spatial genomics, which may enhance the diagnosis and treatment of Non-Small Cell Lung Cancer (NSCLC). Spatial genomics offers detailed insights into cancer cells and their environment, potentially leading to more personalised and timely treatment plans.
Who Can Participate: Adults aged 18 years or older diagnosed with NSCLC.
Participation Details: Participants will engage in a 30–45-minute interview, conducted over the phone or in person at a convenient time. The discussion will focus on experiences with the current diagnostic process and perspectives on integrating new technologies like spatial genomics into cancer care.
How to Participate: Please click on the [REDCap link] to access the Participant Information Sheet and provide consent. After consenting, the UNSW research team will contact you to schedule the interview.
Questions: For more information, contact Dr. Sara Soleymani, the study’s principal investigator, at s.soleymani@unsw.edu.au.
